MRI Scanning software company gets funded -
Sales now will reach millions in current year.
BUY NASDAQ: MSGL (OTC BB) Medical Technology Sector
CANONSBURG, Pa.--(BUSINESS WIRE)--Feb. 5, 2003
-MicroSignal Corp. (OTC BB: MSGL) announced that it
has applied for a five-year, collateralized loan in the
amount of $1.5 million and is currently being reviewed
by lending institutions in Italy and Switzerland. Under
terms of the agreement, the company will issue treasury
shares to secure the loan. The shares would be held in
trust until the loan is repaid and may not be deposited
into a brokerage account for sale by the lender without
proof of default by the company. The application terms
are a five-year period at 5.5 % interest with interest-
only payments during the first year. The company is
seeking favorable financing through this and other sources
to launch an aggressive marketing and sales campaign with
the intent to develop national sales channels to promote
MicroSignal's SLICES(TM) technology, used in MRI imaging.
Proceeds from funding efforts will be further used to
enhance the base technology.
MRI Scanning Software Systems Groundbreaking Upgrade
Allows 10X more Resolution, at 10% of the cost of a new
machine; A Proven market of $1.3B exists for this product.
The product is patented, FDA approved and currently just
beginning to be implemented at many major institutions.
The software allows for MRI resolutions of up to 1.3
Tesla’s compared to existing clarity of .5 Tesla’s.
OTCBB: MSGL is poised to move quickly with solid
fundamentals now in place.
Exchange Listing------NASDAQ OTCBB
Capital Structure-----Total Float/DTC 5.8m,
of which 4.4 million are tightly held/friendly
30-day Avg Volume-----40,000
30-day price target---$0.50
NASDAQ OTCBB: MSGL - Listed Medical Technology MRI
Software Company MSGL – Developers of a Revolutionary
MRI upgrade software package (currently being implemented
in facilities across the U.S.) that produces images with
up to 10X more clarity and resolution than standard MRI
processing software at a fraction of the price.
MSGL’s ground-breaking SLICES(TM) software manipulates raw
data matrices obtained through the MRI scanning process.
Through the use of advanced calculations (MicroSignal's
EXACT method), SLICES(TM) is able to produce images that
boast up to 10 times more clarity and resolutions than
standard MRI processing software.
In addition to superior image quality, and because of the
method of processing, SLICES(TM) is able to significantly
reduce patient scan time and the need for patient call
backs and rescanning. These factors also can contribute
to a reduction in film consumption of up to 40%.
At the end of 2002, there were approximately 10,500
MRI (magnetic resonance imaging) systems installed
worldwide. While changes in medical reimbursement have
slowed the sale of new MRI machines, there has been
an ever increasing demand for improved image quality
and reduced patient scan time; thus there has been a
tremendous need for products that can improve patient
throughput and image quality. OTCBB: MSGL has solved
this problem with its low cost software that upgrades
existing installed MRI systems to the quality of a new
machine at a savings of approximately $1.4 million per
The total estimated market for this system is in excess
of $1.3B. NASDAQ OTCBB: MSGL is expected to capture
approximately 40% of this market within 3 years, resulting
in revenues of approximately $500 million, with a Net
Margin of approximately 35%, or over $100 million in
Other medical technology / software & system developers
such as Baxter Medical NYSE: BAX – p/e of 20X; NASDAQ:
NMMD, p/e of 31.4, NASDAQ: NMDC, p/e of 20X; an average
of 24X current EPS, and 20X 1 yr forward expected earnings.
In comparison to these valuations, NASDAQ OTCBB: MSGL,
with its proven market for its product, sales on the
books for the current quarter and a successful product
launch already would be more fairly valued at 25X –to-
30X forward earnings or $2.00 –to- $3.00 per share
For more information, see the company’s website at:
Information within this email contains "forward looking
statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21B of the Securities
Exchange Act of 1934. Any statements that express or
involve discussions with respect to predictions, goals,
expectations, beliefs, plans, projections, objectives,
assumptions or future events or performance are not
statements of historical fact and may be "forward
Forward looking statements are based on expectations,
estimates and projections at the time the statements
are made that involve a number of risks and uncertainties
which could cause actual results or events to differ
materially from those presently anticipated. Forward
looking statements in this action may be identified
through the use of words such as: "projects", "foresee",
"expects", "estimates," "believes," "understands" "will,"
"anticipates," or that by statements indicating certain
actions "may," "could," or "might" occur. All information
provided within this email pertaining to investing, stocks,
securities must be understood as information provided and
not investment advice. Emerging Equity Alert advises all
readers and subscribers to seek advice from a registered
professional securities representative before deciding to
trade in stocks featured within this email. None of the
material within this report shall be construed as any kind
of investment advice.
In compliance with the Securities Act of 1933,
Section 17(b), Emerging Stock Alert discloses the
receipt of 250,000 unrestricted shares of MSGL from
a third party for the publication of this report. Be
aware of an inherent conflict of interest resulting
from such compensation due to our intent to profit
from the liquidation of these shares. Shares may be
sold at any time, even after positive statements have
been made regarding the above company. All factual
information in this report was gathered from public
sources, including but not limited to SEC filings,
Company Press Releases, and Market Guide. Emerging
Equity Alert believes this information to be reliable
but can make no guarantee as to its accuracy or
completeness. Use of the material within this email
constitutes your acceptance of these terms.
****** Advertising Disclaimer ******
We are an internet advertising company and have received
a monetary payment for this mailing service We hold no
stocks and have no personal interest in this company
whatsoever. We are simply being paid to perform a service.
This message is an advertisement.
****** Removal Instructions ******
This message has been sent to you in compliance with
our strict anti-abuse regulations. We will continue to
bring you valuable offers on the products and services
that interest you most. If you do not wish to receive
further mailings, please click below. We respect all
removal requests. To be removed immediately from our
mailing lists just click on the link below:
Be sure that "delete" is in the subject line
of the email prior to sending it.
To Unsubscribe: send mail to majordomo(at)de.FreeBSD.org
with "unsubscribe de-bsd-test" in the body of the message
Received on Fri 07 Feb 2003 - 20:47:18 CET